Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
Cell ; 186(1): 209-229.e26, 2023 01 05.
Article in English | MEDLINE | ID: mdl-36608654

ABSTRACT

Transcription factors (TFs) regulate gene programs, thereby controlling diverse cellular processes and cell states. To comprehensively understand TFs and the programs they control, we created a barcoded library of all annotated human TF splice isoforms (>3,500) and applied it to build a TF Atlas charting expression profiles of human embryonic stem cells (hESCs) overexpressing each TF at single-cell resolution. We mapped TF-induced expression profiles to reference cell types and validated candidate TFs for generation of diverse cell types, spanning all three germ layers and trophoblasts. Targeted screens with subsets of the library allowed us to create a tailored cellular disease model and integrate mRNA expression and chromatin accessibility data to identify downstream regulators. Finally, we characterized the effects of combinatorial TF overexpression by developing and validating a strategy for predicting combinations of TFs that produce target expression profiles matching reference cell types to accelerate cellular engineering efforts.


Subject(s)
Cell Differentiation , Transcription Factors , Humans , Chromatin , Gene Expression Regulation , Human Embryonic Stem Cells/metabolism , Transcription Factors/metabolism , Atlases as Topic
4.
Nature ; 548(7667): 343-346, 2017 08 17.
Article in English | MEDLINE | ID: mdl-28792927

ABSTRACT

Mammalian genomes contain thousands of loci that transcribe long noncoding RNAs (lncRNAs), some of which are known to carry out critical roles in diverse cellular processes through a variety of mechanisms. Although some lncRNA loci encode RNAs that act non-locally (in trans), there is emerging evidence that many lncRNA loci act locally (in cis) to regulate the expression of nearby genes-for example, through functions of the lncRNA promoter, transcription, or transcript itself. Despite their potentially important roles, it remains challenging to identify functional lncRNA loci and distinguish among these and other mechanisms. Here, to address these challenges, we developed a genome-scale CRISPR-Cas9 activation screen that targets more than 10,000 lncRNA transcriptional start sites to identify noncoding loci that influence a phenotype of interest. We found 11 lncRNA loci that, upon recruitment of an activator, mediate resistance to BRAF inhibitors in human melanoma cells. Most candidate loci appear to regulate nearby genes. Detailed analysis of one candidate, termed EMICERI, revealed that its transcriptional activation resulted in dosage-dependent activation of four neighbouring protein-coding genes, one of which confers the resistance phenotype. Our screening and characterization approach provides a CRISPR toolkit with which to systematically discover the functions of noncoding loci and elucidate their diverse roles in gene regulation and cellular function.


Subject(s)
Drug Resistance, Neoplasm/genetics , Genetic Loci/genetics , Genome, Human/genetics , Indoles/pharmacology , Melanoma/genetics , RNA, Long Noncoding/genetics , Sulfonamides/pharmacology , Transcriptional Activation/genetics , CRISPR-Cas Systems/genetics , Cell Line, Tumor , Drug Resistance, Neoplasm/drug effects , Genetic Loci/drug effects , Hippo Signaling Pathway , Humans , Indoles/therapeutic use , Melanoma/drug therapy , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Phenotype , Promoter Regions, Genetic/genetics , Protein Kinase Inhibitors/pharmacology , Protein Kinase Inhibitors/therapeutic use , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins B-raf/antagonists & inhibitors , Signal Transduction/drug effects , Sulfonamides/therapeutic use , Transcription Initiation Site , Vemurafenib
5.
Neuron ; 72(1): 72-85, 2011 Oct 06.
Article in English | MEDLINE | ID: mdl-21982370

ABSTRACT

Autism spectrum disorders such as Rett syndrome (RTT) have been hypothesized to arise from defects in experience-dependent synapse maturation. RTT is caused by mutations in MECP2, a nuclear protein that becomes phosphorylated at S421 in response to neuronal activation. We show here that disruption of MeCP2 S421 phosphorylation in vivo results in defects in synapse development and behavior, implicating activity-dependent regulation of MeCP2 in brain development and RTT. We investigated the mechanism by which S421 phosphorylation regulates MeCP2 function and show by chromatin immunoprecipitation-sequencing that this modification occurs on MeCP2 bound across the genome. The phosphorylation of MeCP2 S421 appears not to regulate the expression of specific genes; rather, MeCP2 functions as a histone-like factor whose phosphorylation may facilitate a genome-wide response of chromatin to neuronal activity during nervous system development. We propose that RTT results in part from a loss of this experience-dependent chromatin remodeling.


Subject(s)
Brain/growth & development , Exploratory Behavior/physiology , Gene Expression Regulation, Developmental/physiology , Genome/physiology , Methyl-CpG-Binding Protein 2/genetics , Methyl-CpG-Binding Protein 2/physiology , Animals , Brain/metabolism , Brain/physiology , Chromatin/metabolism , Chromatin Immunoprecipitation/methods , Dendrites/physiology , Gene Expression Regulation, Developmental/genetics , Gene Knock-In Techniques/methods , Methyl-CpG-Binding Protein 2/metabolism , Mice , Mice, Inbred C57BL , Neurons/cytology , Neurons/metabolism , Neurons/physiology , Phosphorylation
SELECTION OF CITATIONS
SEARCH DETAIL
...